Philip L. Johnson - 05 Mar 2025 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role
EVP & Chief Financial Officer
Signature
By: /s/Adam Guttmann, as attorney in fact For: Philip L. Johnson
Issuer symbol
JAZZ
Transactions as of
05 Mar 2025
Transactions value $
-$159,654
Form type
4
Filing time
07 Mar 2025, 18:51:44 UTC
Previous filing
03 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Disposed to Issuer -$160K -1.15K -2.24% $138.95 50.1K 05 Mar 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.